If you took Invokana or Invokamet and suffered ketoacidosis you may have legal options.
In May of 2015 the FDA issued a warning stating that sodium-glucose cotransporter-2 (SGLT2) inhibitors prescribed to treat type 2 diabetes “may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization.”
The FDA is currently recommending that people taking SGLT2 medications such as Invokana and Invokamet pay close attention for any signs of ketoacidosis and seek medical attention immediately if they experience symptoms such as: difficulty breathing, nausea, vomiting, abdominal pain, confusion, and unusual fatigue or sleepiness.
SGLT2 inhibitors such as Invokana and Invokamet work by sending glucose out of the body in a person’s urine. Whereas insulin works to help the body metabolize blood sugars better, Invokana works by blocking reabsorption of glucose back into the blood stream and then excreting it through the urine. This can potentially strain the kidneys, which are not naturally equipped to deal with high levels of glucose.
The Institute for Safe Medication Practices (ISMP) warned in a recent report that there are still unanswered questions about Canagliflozin, the active ingredient in both Invokana and Invokamet. The ISMP states, “the unanswered question about canagliflozin—shared in part by other diabetes medications—is whether it has clinical benefits, and whether those benefits outweigh its risks.” The report went on to warn of “increasing evidence that canagliflozin is associated with adverse effects in appropriate clinical use.” The ISMP noted they had received 457 reports of serious events related to Invokana.
Since Invokana and Invokamet came on the market in 2013, the FDA Adverse Event Reporting System (FAERS) has reported a small group of patients that have required hospitalization due to at least one of the following symptoms:
– Diabetic Ketoacidosis (DKA)
– Diabetic Coma
– Renal Failure
– Reduced Kidney Function
Because of these potentially fatal side effects, investigations are now underway against the drug manufacturer. If you took Invokana or Invokamet and suffered ketoacidosis you may have legal options.
If you or a loved one has been hospitalized for ketoacidosis, diabetic coma, or kidney failure while taking Invokana or Invokamet, please contact us today for a free, no-obligation consultation about your potential case.
Experience in Dangerous Drug and Medical Device Cases
Defending the Rights of the Consumer
At GJEL Accident Attorneys, our more than thirty years of experience assures you that we will investigate the cause of an accident caused by a defective product, obtain the opinions of the best experts in the industry, and fight for your rights to just compensation. We have played a leading role in two of California’s largest medical lawsuits in the last ten years–a $1.05 Billion national settlement with Sulzer AG for surgeries related to defective hip and knee implants, and a $417 Million settlement with Tenet Healthcare for its role in unnecessary heart surgeries at Redding Medical Center. In both cases, attorney Luke Ellis was appointed by the courts to serve as one of the lead plaintiffs attorneys in the Judicial Council Coordinated Proceedings (JCCP).
In the Sulzer case, more than 3,000 people had to have surgery to replace their defective hip and knee implants, and approximately 1,000 more who were unable to undergo replacement surgery were covered by the settlement.